Medicine News and Research

RSS

Harvard Bioscience's novel bioreactor technology featured on National Geographic Channel

Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, is pleased to announce that its novel bioreactor technology was featured on the National Geographic Channel's Explorer television program on February 7, 2011.

From Harvard Bioscience 11 Feb 2011

BIDPO implements Ingenix technology to measure clinical, operational performance

Beth Israel Deaconess Physician Organization (BIDPO) has contracted with Ingenix to help its doctors measure clinical performance to reduce variations in care - capabilities essential to BIDPO's plans to operate successfully under anticipated state and national payment reform changes.

11 Feb 2011

Participation in preterm birth prevention clinics reduces risk of recurrent spontaneous preterm births

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that when women at high risk for preterm birth participated in a preterm birth prevention clinic, more women delivered full term babies and there were fewer cases of infant morbidity.

11 Feb 2011

Vaccinating through salivary glands may provide protection against wide range of diseases

If you don't like shots or needles, you're in luck. New research published online in The FASEB Journal gives the development of new oral vaccinations a shot in the arm thanks to discoveries involving the salivary glands of mice. In addition, this research report also offers a tantalizing glimpse of vaccines that could prevent infection at mucosal surfaces, even if direct injections into the body fail to cause immunity. This technique may be effective for a wide range of diseases from influenza to cholera.

11 Feb 2011

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Genetic testing for inherited blood-clotting abnormalities is not routinely recommended for patients with venous thromboembolism (VTE) of unknown cause, according to a new expert panel statement in a recent issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG).

11 Feb 2011

Blocking interleukin 15 may help restore oral tolerance to gluten

Blocking a factor that can activate the human immune response against intestinal bacteria or certain foods could prevent the development of celiac disease in those most at risk, researchers report in the journal Nature.

11 Feb 2011

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P."

11 Feb 2011

The .brain format may be the best compression algorithm, for now

Most of us are familiar with the idea of image compression in computers. File extensions like ".jpg" or ".png" signify that millions of pixel values have been compressed into a more efficient format, reducing file size by a factor of 10 or more with little or no apparent change in image quality. The full set of original pixel values would occupy too much space in computer memory and take too long to transmit across networks.

11 Feb 2011

First 7 stem cell lines grown at UMMS Human Stem Cell Bank ready for global distribution

The first seven stem cell lines grown and banked at the University of Massachusetts Medical School's Human Stem Cell Bank are ready for worldwide distribution to researchers working on discovering new therapeutic treatments for diseases such as cancer, juvenile diabetes, Alzheimer's and Parkinson's, among others.

11 Feb 2011

Richard J. Fasenmyer Foundation awards $3M to Cleveland physicians for AIDS research

A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.

11 Feb 2011

Despite fetal pulmonary maturity, babies delivered prior to 39 weeks are at risk

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that despite fetal pulmonary maturity, babies delivered at between 36 to 38 weeks, still have a significantly increased risk of neonatal morbidities.

11 Feb 2011

Rapid GBS test useful adjunct to third trimester culture for accurate GBS detection at time of labor

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that many women are having different test results for Group B streptococcus (GBS) between their routine third trimester screening and a rapid test performed at the time of labor.

11 Feb 2011

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem-, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

11 Feb 2011

Seven-year study demonstrates clear benefits of fetal surgery to treat spina bifida in babies

Results of a landmark, seven-year National Institutes of Health-funded trial, Management of Myelomeningocele Study (MOMS), demonstrate clear benefit for babies who undergo fetal surgery to treat spina bifida, the most common birth defect in the central nervous system.

11 Feb 2011

Viral infection of Leishmania leads to increased pathogenicity

A parasite and a virus may be teaming up in a way that increases the parasite's ability to harm humans, scientists at the University of Lausanne in Switzerland and Washington University School of Medicine in St. Louis report this week in Science.

11 Feb 2011

Study finds too low drug concentrations used for treatment of children with TB

The realization of medically treating different children uniquely may start with one of the deadliest diseases in existence: tuberculosis.

11 Feb 2011

Scientists develop novel treatment strategy for multiple myeloma

Scientists at Virginia Commonwealth University Massey Cancer Center have developed a novel treatment strategy for multiple myeloma that pairs two targeted agents to kill cancer cells. The study's findings, published in today's edition of the journal "Blood," are the first to demonstrate the synergistic, anti-myeloma effects of this combination regimen both in vitro and in vivo.

11 Feb 2011

Preladenant may offer new supplemental treatment for Parkinson's disease: Study

Preladenant, a non-dopaminergic medication, reduces off time in patients with Parkinson's disease receiving standard dopamine therapy, an international study led by the University of South Florida found.

11 Feb 2011

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

New findings from a McMaster University-led study of a drug recently identified to prevent stroke in patients with atrial fibrillation have been published in the high-impact New England Journal of Medicine today.

11 Feb 2011

Patients with high blood pressure have benign endocrine tumours in adrenal gland: Research

High blood pressure may in some cases be caused by benign hormone-producing tumours of the adrenal cortex. A joint Swedish-American research effort has now uncovered a genetic cause behind the occurrence of such tumours. The findings were published today in the journal Science.

11 Feb 2011

Medicine News and Research

Harvard Bioscience's novel bioreactor technology featured on National Geographic Channel

BIDPO implements Ingenix technology to measure clinical, operational performance

Participation in preterm birth prevention clinics reduces risk of recurrent spontaneous preterm births

Vaccinating through salivary glands may provide protection against wide range of diseases

Genetic testing for inherited blood-clotting abnormalities not routinely recommended for VTE patients

Blocking interleukin 15 may help restore oral tolerance to gluten

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

The .brain format may be the best compression algorithm, for now

First 7 stem cell lines grown at UMMS Human Stem Cell Bank ready for global distribution

Richard J. Fasenmyer Foundation awards $3M to Cleveland physicians for AIDS research

Despite fetal pulmonary maturity, babies delivered prior to 39 weeks are at risk

Rapid GBS test useful adjunct to third trimester culture for accurate GBS detection at time of labor

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Seven-year study demonstrates clear benefits of fetal surgery to treat spina bifida in babies

Viral infection of Leishmania leads to increased pathogenicity

Study finds too low drug concentrations used for treatment of children with TB

Scientists develop novel treatment strategy for multiple myeloma

Preladenant may offer new supplemental treatment for Parkinson's disease: Study

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

Patients with high blood pressure have benign endocrine tumours in adrenal gland: Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News